Treatment of Urinary Tract Infections in Men
All urinary tract infections in men are classified as complicated UTIs and require 7–14 days of antibiotic therapy, with 14 days preferred when prostatitis cannot be excluded. 1, 2
Initial Diagnostic Steps
Before initiating treatment, obtain a urine culture with susceptibility testing in all male patients with UTI symptoms, as this population has a broader microbial spectrum and higher antimicrobial resistance rates compared to women with uncomplicated cystitis. 1, 2 The most common pathogens include E. coli, Proteus spp., Klebsiella spp., Pseudomonas spp., Serratia spp., and Enterococcus spp. 1
Evaluate for underlying urological abnormalities that define complicated UTIs: obstruction at any site in the urinary tract, incomplete bladder emptying (elevated post-void residual), indwelling catheters or foreign bodies, recent instrumentation, diabetes mellitus, or immunosuppression. 1, 2 Appropriate management of any underlying urological abnormality is mandatory, as antimicrobial therapy alone is insufficient without source control. 1
First-Line Empiric Oral Therapy
When Fluoroquinolone Resistance is <10%
Ciprofloxacin 500–750 mg orally twice daily for 7–14 days is the preferred first-line empiric option when local fluoroquinolone resistance remains below 10% and the patient has no recent fluoroquinolone exposure within the past 3 months. 1, 2 Alternatively, levofloxacin 750 mg orally once daily for 5–7 days provides equivalent efficacy with once-daily dosing convenience. 1, 2
Reserve fluoroquinolones for second-line use if local resistance exceeds 10% or if the patient has recent fluoroquinolone exposure, as serious adverse effects (tendinopathy, QT prolongation, central nervous system toxicity) may outweigh benefits. 2, 3
Alternative First-Line Options
Trimethoprim-sulfamethoxazole 160/800 mg orally twice daily for 14 days is an appropriate alternative when the pathogen is susceptible and fluoroquinolones are contraindicated or unavailable. 1, 2, 4 However, this agent should only be used if local E. coli resistance rates are <20% or if the organism is known to be susceptible on culture. 3, 4
Nitrofurantoin 100 mg orally twice daily for 7 days may be considered for lower UTI in men when upper tract involvement (pyelonephritis or prostatitis) can be definitively excluded, though this is often difficult to determine clinically. 2, 5 Nitrofurantoin achieves high urinary concentrations but poor tissue penetration, making it unsuitable when prostatitis is a possibility. 2
Parenteral Therapy for Severe Infections
When the patient presents with systemic symptoms (fever, rigors, hemodynamic instability) or cannot tolerate oral medications, initiate parenteral therapy with ceftriaxone 1–2 g IV/IM once daily (use 2 g for complicated infections). 1, 2 This provides broad-spectrum coverage against common uropathogens while awaiting culture results. 2
Alternative parenteral options include:
- Cefepime 1–2 g IV every 12 hours (use higher dose for severe infections) 2
- Piperacillin-tazobactam 3.375–4.5 g IV every 6–8 hours when multidrug-resistant organisms are suspected 2
- Gentamicin 5 mg/kg IV once daily or amikacin 15 mg/kg IV once daily for aminoglycoside coverage 1, 2
Transition to oral therapy once the patient is afebrile for ≥48 hours, hemodynamically stable, and culture results are available. 1, 2 The total course (IV plus oral) should be 7–14 days, with 14 days preferred for male patients when prostatitis cannot be excluded. 1, 2
Treatment Duration Algorithm
7-day total course: Appropriate when symptoms resolve promptly, the patient remains afebrile for ≥48 hours, is hemodynamically stable, and there is no evidence of upper tract involvement or urological abnormalities. 1, 2
14-day total course: Required for delayed clinical response (persistent fever >72 hours), when prostatitis cannot be definitively excluded (which is most male UTI cases), or when underlying urological abnormalities are present. 1, 2
Culture-Directed Therapy Adjustment
Once susceptibility results return, tailor therapy to the specific organism and resistance pattern. 1, 2 If the initial empiric agent shows susceptibility, continue to complete the appropriate duration. 2 If resistance is documented, switch to an appropriate agent based on sensitivities. 2
Critical Pitfalls to Avoid
Do not use the 3–5 day short-course regimens recommended for uncomplicated cystitis in women; all UTIs in men require 7–14 days of therapy. 2, 5 The short-duration fluoroquinolone regimen for uncomplicated cystitis in women should never be applied to men, as this leads to higher relapse rates. 2
Do not treat asymptomatic bacteriuria in catheterized or non-catheterized men, as this increases antimicrobial resistance without clinical benefit. 1, 2, 3 Treatment is only indicated for symptomatic infections. 2
Avoid nitrofurantoin and fosfomycin when upper tract involvement (pyelonephritis or prostatitis) cannot be excluded, as these agents have insufficient tissue penetration. 2, 3
Do not use moxifloxacin for any urinary tract infection, as its urinary concentrations are uncertain and may be ineffective. 2
Special Considerations
For elderly men (≥65 years), the same first-line antibiotics and treatment durations apply as for younger adults, but obtain urine culture with susceptibility testing to adjust therapy after initial empiric treatment. 5 Age ≥80 years automatically classifies a UTI as complicated, necessitating broader empiric coverage and potentially longer therapy. 2
When Pseudomonas aeruginosa is isolated, ciprofloxacin 500 mg orally every 12 hours for 7–14 days is the recommended oral regimen, with 14 days preferred when prostatitis cannot be excluded. 2 For severe Pseudomonas infections requiring parenteral therapy, use cefepime 2 g IV every 8 hours. 2